What BPC-157 is
BPC-157 (Body Protection Compound 157) is a 15-amino acid synthetic peptide derived from a protein sequence found in human gastric juice. Animal studies have shown effects including:
- Accelerated healing of tendons and ligaments at the tendon-to-bone interface
- Reduced muscle inflammation and improved recovery from contusions and tears
- Effects on the nitric oxide (NO) signaling pathway, which influences blood vessel formation and tissue repair
- Possible gut-protective effects in gastrointestinal contexts
The research base is primarily animal model data. Human clinical trial evidence is limited, which is why BPC-157 remains outside FDA approval. However, it is legally prescribable as a compounded medication by a licensed US physician.
Primary uses in US clinics:
- Tendon and ligament injuries (Achilles tendon, rotator cuff, knee ligaments)
- Muscle tears and chronic muscle injuries
- Joint inflammation
- Post-surgical recovery
- Gastrointestinal healing (some clinics use oral BPC-157 for gut applications)
What TB-500 is
TB-500 is a synthetic peptide derived from Thymosin Beta-4 (TB-4), a naturally occurring protein in virtually all human and animal cells. Thymosin Beta-4 plays a role in:
- Actin regulation (the protein involved in cell movement and structure)
- Reducing inflammation
- Promoting blood vessel formation (angiogenesis)
- Stimulating satellite cells involved in muscle repair
TB-500 specifically refers to the active fragment of Thymosin Beta-4 responsible for most of its regenerative activity. Like BPC-157, the research base is largely animal models, though Thymosin Beta-4 (the parent molecule) has been studied in some human wound healing and cardiac contexts.
Primary uses in US clinics:
- Systemic anti-inflammatory and recovery support
- Muscle and connective tissue healing
- Cardiovascular tissue recovery (more experimental)
- Sometimes used for hair loss (small research base)
Key differences
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice protein fragment | Thymosin Beta-4 active fragment |
| Primary mechanism | NO pathway, growth factor signaling | Actin regulation, angiogenesis |
| Best documented use | Tendon/ligament repair | Systemic anti-inflammatory, muscle repair |
| Administration | Injectable (SC/IM) or oral | Injectable (SC/IM) |
| FDA status | Not approved, compoundable (503A) | Not approved, compoundable (503A) |
| Typical cost | $100-300/month compounded | $100-400/month compounded |
Why they are often combined
Many physician-supervised programs use BPC-157 and TB-500 together because their mechanisms are complementary:
- BPC-157 is more targeted toward local tissue repair, particularly at tendon-to-bone junctions
- TB-500 provides broader systemic anti-inflammatory support and promotes vascular growth that supports healing
The combination may address different aspects of the repair process simultaneously, which is the clinical rationale for protocols that include both. That said, there is limited controlled human research comparing combination use to either peptide alone.
What a legitimate program looks like
If you are pursuing either or both of these peptides, look for:
- A named prescribing physician with relevant experience (sports medicine, regenerative medicine, longevity medicine)
- A real consultation that assesses your specific injury or recovery goal
- Clear discussion of what the evidence does and does not show for your situation
- Compounded medication from a named, verifiable 503A pharmacy
- Scheduled follow-up to assess response and adjust dosing
Avoid programs that prescribe without a real consultation, use "research use only" labeled products, or cannot name the compounding pharmacy.
Finding a recovery peptide clinic in the US
Browse clinics offering BPC-157 across the US. Related: BPC-157 injury recovery guide.
Browse recovery-focused clinics by state: Texas - California - Florida - Colorado - Arizona - browse all states.